CARDIO inCode-Score® collaboration with Thermo Fisher Scientific
Commercialisation agreement to sell, distribute and manufacture CARDIO inCode-Score® for the genetic risk prediction and prevention of coronary heart disease OXFORD, UNITED KINGDOM, December 4, 2025 /EINPresswire.com/ -- GENinCode Plc (AIM: GENI), the Oxford based predictive genetics company focused on the prevention of cardiovascular disease (“CVD”) and risk assessment of ovarian cancer, announces today a collaboration with Thermo Fisher Scientific to sell, distribute and manufacture the CARDIO inCode- …